Evaxion Biotech A/S
USD3.02
+0.08 (+2.72%)
CEO
Helen Katrina Tayton-Martin
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
DK
Open
$2.96
Prev. Close
$2.94
Day Low
$2.94
Day High
$3.03
52W Low
$2.45
52W High
$12.15
Market Cap
$0.02B
Volume
0.01M
| -0.4 |
| 31 Dec 2023 | FY | 100.0% | -30308.2% | 467.9% | -171.7% | -2.30 | 1.18 | -1.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -279.0% | -105.2% | 1.24 | 4.51 | -2.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -75.6% | -61.1% | 0.11 | 8.03 | -4.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -213.4% | -125.5% | 0.00 | 2.22 | -13.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -119.6% | -101.0% | 0.00 | 6.36 | -17.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 594.5% | -65.0% | -9.31 | 0.89 | -42.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.06 | 9.04 | 0.0 |
| 30 Sept 2025 | Q3 | 100.0% | 61.6% | 27.8% | 15.5% | 0.00 | 0.00 | 0.2 |
| 30 Jun 2025 | Q2 | 100.0% | -13056.8% | -77.6% | -21.5% | 1.81 | 3.42 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -15.3% | -6.3% | 0.00 | 0.00 | -0.3 |
| 31 Dec 2024 | Q4 | 100.0% | -2974.6% | 219.7% | -29.1% | -6.11 | 2.01 | -0.3 |
| 30 Sept 2024 | Q3 | 100.0% | -64.1% | -2614.9% | -12.7% | 0.00 | 0.00 | -2.8 |
| 30 Jun 2024 | Q2 | 100.0% | -4024.7% | -494.7% | -40.7% | 8.37 | 2.80 | -0.8 |
| 31 Mar 2024 | Q1 | 100.0% | 2341.2% | 45.9% | 5.3% | 0.00 | 0.00 | 3.9 |
| 31 Dec 2023 | Q4 | 100.0% | -6195.9% | 95.6% | -35.1% | -2.30 | 1.18 | -1.3 |